
NYSEHealthcareMedical - Devices
أحدث البيانات المتاحة
126.61 US$
−0.04 US$ · -0.03%
Integer Holdings Corporation functions as a global leader in outsourced medical device manufacturing, maintaining operations across the United States, Puerto Rico, Costa Rica, and other international regions. The company organizes its business into two primary divisions: Medical and Non-Medical. Within its Medical segment, Integer delivers a broad array of devices and components essential for numerous advanced medical procedures. These solutions cater to areas such as interventional cardiology, structural heart conditions, heart failure management, peripheral and neurovascular interventions, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology. Their extensive product portfolio includes cardiac rhythm management devices like implantable pacemakers, defibrillators, cardiac monitors, leads, and heart failure therapies. They also produce neuromodulation devices, such as implantable spinal cord stimulators, alongside critical components like non-rechargeable batteries, feedthroughs, device enclosures, precision-machined parts, and lead sub-assemblies. Furthermore, Integer provides rechargeable battery systems and chargers. A comprehensive range of surgical instruments and components is also offered for arthroscopic, laparoscopic, and general surgery, encompassing items like harmonic scalpels, various blades and shavers, radio frequency and biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment parts, and phacoemulsification needles. Orthopedic offerings comprise specialized instruments for hip, knee, and spine surgeries, including reamers and chisels, among other general medical technologies. The Non-Medical segment concentrates on developing customized battery power and management systems, along with specialized battery solutions, designed for the energy, military, and environmental sectors. Integer primarily collaborates with multinational original equipment manufacturers (OEMs) and their affiliated subsidiaries, supporting their requirements across diverse markets, including cardiac, neuromodulation, orthopedics, vascular, advanced surgical, and portable medical applications. Established in 1970, Integer Holdings Corporation is headquartered in Plano, Texas.
عند الإغلاق
126.61 US$
−0.04 US$ · -0.03%
بعد ساعات التداول
126.75 US$
+0.1397 US$ · +0.11%
9 أكتوبر، 4:01 م ET
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
Integer Holdings Corporation functions as a global leader in outsourced medical device manufacturing, maintaining operations across the United States, Puerto Rico, Costa Rica, and other international regions. The company organizes its business into two primary divisions: Medical and Non-Medical. Within its Medical segment, Integer delivers a broad array of devices and components essential for numerous advanced medical procedures. These solutions cater to areas such as interventional cardiology, structural heart conditions, heart failure management, peripheral and neurovascular interventions, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology. Their extensive product portfolio includes cardiac rhythm management devices like implantable pacemakers, defibrillators, cardiac monitors, leads, and heart failure therapies. They also produce neuromodulation devices, such as implantable spinal cord stimulators, alongside critical components like non-rechargeable batteries, feedthroughs, device enclosures, precision-machined parts, and lead sub-assemblies. Furthermore, Integer provides rechargeable battery systems and chargers. A comprehensive range of surgical instruments and components is also offered for arthroscopic, laparoscopic, and general surgery, encompassing items like harmonic scalpels, various blades and shavers, radio frequency and biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment parts, and phacoemulsification needles. Orthopedic offerings comprise specialized instruments for hip, knee, and spine surgeries, including reamers and chisels, among other general medical technologies. The Non-Medical segment concentrates on developing customized battery power and management systems, along with specialized battery solutions, designed for the energy, military, and environmental sectors. Integer primarily collaborates with multinational original equipment manufacturers (OEMs) and their affiliated subsidiaries, supporting their requirements across diverse markets, including cardiac, neuromodulation, orthopedics, vascular, advanced surgical, and portable medical applications. Established in 1970, Integer Holdings Corporation is headquartered in Plano, Texas.
نطاق اليوم
السعر الحالي 126.61 US$
نطاق 52 أسبوعًا
السعر الحالي 126.61 US$
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
نقاط GoAI
شراء
تقييم
92
قيمة جذابة جدًا
المشاعر
68
صعودي
المخاطر
30
مخاطر متوسطة
الزخم
46
محايد
بحث كامل عن GoAI
تابع للاطلاع على أدلة ومحفزات ومخاطر أعمق.
Integer Holdings Corporation functions as a global leader in outsourced medical device manufacturing, maintaining operations across the United States, Puerto Rico, Costa Rica, and other international regions. The company organizes its business into two primary divisions: Medical and Non-Medical. Within its Medical segment, Integer delivers a broad array of devices and components essential for numerous advanced medical procedures. These solutions cater to areas such as interventional cardiology, structural heart conditions, heart failure management, peripheral and neurovascular interventions, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology. Their extensive product portfolio includes cardiac rhythm management devices like implantable pacemakers, defibrillators, cardiac monitors, leads, and heart failure therapies. They also produce neuromodulation devices, such as implantable spinal cord stimulators, alongside critical components like non-rechargeable batteries, feedthroughs, device enclosures, precision-machined parts, and lead sub-assemblies. Furthermore, Integer provides rechargeable battery systems and chargers. A comprehensive range of surgical instruments and components is also offered for arthroscopic, laparoscopic, and general surgery, encompassing items like harmonic scalpels, various blades and shavers, radio frequency and biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment parts, and phacoemulsification needles. Orthopedic offerings comprise specialized instruments for hip, knee, and spine surgeries, including reamers and chisels, among other general medical technologies. The Non-Medical segment concentrates on developing customized battery power and management systems, along with specialized battery solutions, designed for the energy, military, and environmental sectors. Integer primarily collaborates with multinational original equipment manufacturers (OEMs) and their affiliated subsidiaries, supporting their requirements across diverse markets, including cardiac, neuromodulation, orthopedics, vascular, advanced surgical, and portable medical applications. Established in 1970, Integer Holdings Corporation is headquartered in Plano, Texas.
نطاق اليوم
السعر الحالي 126.61 US$
نطاق 52 أسبوعًا
السعر الحالي 126.61 US$
الربحية كنسبة مئوية من الإيرادات المعلنة.
الإيرادات
الدخل التشغيلي
صافي الدخل
| البند (USD) | السنة المالية 2025 | السنة المالية 2024 | السنة المالية 2023 | السنة المالية 2022 | السنة المالية 2021 |
|---|---|---|---|---|---|
| الإيرادات | 1.85 مليار USD | 1.72 مليار USD | 1.56 مليار USD | 1.33 مليار USD | 1.22 مليار USD |
| تكلفة البضاعة المباعة | 1.42 مليار USD | 1.26 مليار USD | 1.14 مليار USD | 984.63 مليون USD | 884.11 مليون USD |
| الربح الإجمالي | 425.81 مليون USD | 461.18 مليون USD | 411.52 مليون USD | 346.65 مليون USD | 336.97 مليون USD |
| البحث والتطوير | 46.35 مليون USD | 53.43 مليون USD | 61.97 مليون USD | 59.76 مليون USD | 51.99 مليون USD |
| مصاريف البيع والمصاريف العمومية والإدارية | 162.59 مليون USD | 184.33 مليون USD | 171.47 مليون USD | 157.36 مليون USD | 141.69 مليون USD |
| نفقات التشغيل | 216.55 مليون USD | 252.95 مليون USD | 248.2 مليون USD | 233.97 مليون USD | 201.26 مليون USD |
| مصاريف الفوائد | 42.31 مليون USD | 56.37 مليون USD | 53.37 مليون USD | 37.27 مليون USD | 31.63 مليون USD |
| الاستهلاك والإطفاء | 130.67 مليون USD | 111.03 مليون USD | 98.84 مليون USD | 91.99 مليون USD | 81.37 مليون USD |
| الدخل التشغيلي | 209.27 مليون USD | 208.24 مليون USD | 163.32 مليون USD | 112.68 مليون USD | 135.71 مليون USD |
| صافي الدخل | 102.76 مليون USD | 119.9 مليون USD | 90.65 مليون USD | 66.38 مليون USD | 96.81 مليون USD |
تم تحديث حقائق الشركة 9 أكتوبر 2026.
أحدث النتائج المعلنة
أحدث النتائج المعلنة
قد تتغير تقديرات المحللين الخارجيين، وهي ليست توصيات من GoAI.
متوسط الهدف
118.25 US$
انخفاض محتمل بنسبة 6.60%صناديق متداولة تفصح عن تعرضها لهذا السهم.
Vanguard Morningstar Total Stock Market ETFVTI135.63 مليون0.01%2.3 ترليون USD0.03%381.94 US$+0.63%
iShares Russell 2000 ETFIWM114.4 مليون0.15%77.7 مليار USD0.19%278.94 US$+0.49%
Vanguard Morningstar Small-Cap ETFVB97.76 مليون0.05%185.3 مليار USD0.03%289.48 US$+0.64%
Vanguard Morningstar Small-Cap Value ETFVBR62.14 مليون0.09%68.2 مليار USD0.05%234.43 US$+0.22%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV49.85 مليون0.19%26.91 مليار USD0.33%37.95 US$-0.39%
Vanguard Extended Market ETFVXF49.43 مليون0.05%95.4 مليار USD0.05%235 US$+0.80%
iShares Russell 2000 Value ETFIWN40.39 مليون0.29%13.75 مليار USD0.24%210.87 US$-0.04%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM39.6 مليون0.25%15.8 مليار USD0.03%53.45 US$+0.17%
Vanguard Morningstar Total Stock Market ETFVTI
iShares Russell 2000 ETFIWM
Vanguard Morningstar Small-Cap ETFVB
Vanguard Morningstar Small-Cap Value ETFVBR
U.S. Small Cap Value Portfolio ETF Class SharesDFSV
Vanguard Extended Market ETFVXF
iShares Russell 2000 Value ETFIWN
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSMالمحتوى المُنشأ بالذكاء الاصطناعي وبيانات السوق المتأخرة لأغراض معلوماتية وتعليمية فقط، ولا تُعد نصيحة استثمارية.